MedPath

COMPARATIVE STUDY, DOUBLE BLIND, RANDOMIZED, PROSPECTIVE, MULTICENTRIC TO EVALUATE THE SAFETY, LOCAL TOLERABILITY AND CLINICAL RESULTS OF SODIUM ERTAPENEM (MK-0826) AGAINST SODIUM CEFTRIAXONE PATIENT INFLUENCED PEDIAT INFECTED PEDIAT INFLUENCED PEDIAT INFLUENCED PEDIAT INFLUENCED PEDIAT INFLATED PEDIAT INFECTION OR COMMUNITY ACQUIRED PNEUMONIA

Not Applicable
Conditions
-N390 Urinary tract infection, site not specified
Urinary tract infection, site not specified
N390
Registration Number
PER-024-02
Lead Sponsor
MERCK SHARP & DOHME PERU S.R.L.,
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

NA

Exclusion Criteria

NA

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath